-
PVCT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
-
Shorts
Provectus Biopharmaceuticals (PVCT)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 801.65 k | 801.65 k | 801.65 k | 801.65 k | 801.65 k | 801.65 k |
Cash burn (monthly) | (no burn) | 50.71 k | 318.58 k | 233.54 k | 188.33 k | 244.44 k |
Cash used (since last report) | n/a | 250.35 k | 1.57 mm | 1.15 mm | 929.74 k | 1.21 mm |
Cash remaining | n/a | 551.29 k | -771.05 k | -351.28 k | -128.09 k | -405.07 k |
Runway (months of cash) | n/a | 10.9 | -2.4 | -1.5 | -0.7 | -1.7 |
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 12.76 mm |
Total shares | 130.19 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Home Federal Bank Of Tennessee | 100.00 k | $9.80 mm |
LBMC Investment Advisors | 20.00 k | $1.96 mm |
Financial Symmetry | 10.19 k | $998.00 k |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Feb 25 | Pershing Edward | 8% Unsecured Convertible Promissory Note [object Object] | Grant | Acquire A | No | No | 2.862 | - | 125.00 k | - |
15 Feb 25 | Pershing Edward | Series D-1 Convertible Preferred Stock Common Stock | Option exercise | Acquire M | No | No | 0 | 27,989 | 0.00 | 1,827,623 |
15 Feb 25 | Pershing Edward | 8% Unsecured Convertible Promissory Note [object Object] | Option exercise | Dispose M | No | No | 2.862 | - | 75.00 k | - |
30 Jan 25 | Pershing Edward | Series D-1 Convertible Preferred Stock Common Stock | Option exercise | Acquire M | No | No | 0 | 51,290 | 0.00 | 1,799,634 |
30 Jan 25 | Pershing Edward | 8% Unsecured Convertible Promissory Note [object Object] | Option exercise | Dispose M | No | No | 2.862 | - | 135.00 k | - |
30 Jan 25 | Pershing Edward | 8% Unsecured Convertible Promissory Note [object Object] | Grant | Acquire A | No | No | 2.862 | - | 100.00 k | - |
16 Jan 25 | Pershing Edward | 8% Unsecured Convertible Promissory Note [object Object] | Grant | Acquire A | No | No | 2.862 | - | 100.00 k | - |